منابع مشابه
Newborn screening for hemoglobinopathies in California.
BACKGROUND Newborn screening (NBS) for hemoglobinopathies facilitates early identification of affected individuals to ensure the prompt institution of comprehensive medical care for affected newborns in California. When linked to extensive follow-up and education, NBS has been shown to significantly reduce mortality in children with sickle cell disease. Due to changing immigration patterns from...
متن کاملNewborn screening for non-sickling hemoglobinopathies.
The hemoglobinopathies encompass a heterogeneous group of disorders associated with mutations in both the alpha-globin and beta-globin genes. Non-sickling disorders are found primarily in individuals of Mediterranean, Asian and Southeast Asian ancestry. With rapid growth in the Asian and Hispanic segments of the US population, the geographic distribution of hemoglobinopathies is expected to bec...
متن کاملPrenatal and newborn screening for hemoglobinopathies.
The hemoglobinopathies encompass a heterogeneous group of disorders associated with mutations in both the alpha-globin and beta-globin genes. Increased immigration of high-risk populations has prompted the implementation of prenatal and newborn screening programs for hemoglobinopathies across Europe and North America. In Canada, the UK, and other European countries, prenatal screening to identi...
متن کاملScreening for hemoglobinopathies in neonates in Argentina.
nificant lengthening of PFS was the result of IFN maintenance therapy, as already reported.10 Our experience, although limited, confirms the efficacy of purine analogs as second line therapy. In agreement with Rai et al.8 the very high projected survival probability of our series can be explained mainly by a two step therapeutic strategy made up of IFN first line therapy and purine analog salva...
متن کاملAn overview of hemoglobinopathies and the interpretation of newborn screening results.
Sickle cell disease (SCD), thalassemias, and other hemoglobinopathies are major health problems in the United States. It is estimated that there are approximately 100,000 patients with SCD in the United States,1 with approximately 2,000 babies born with SCD every year.2 Historically, infection from capsulated organisms caused high mortality and morbidly in children with SCD. The introduction of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Volume 5, Issue 9, September 2018
سال: 2018
ISSN: 2349-6126,2349-6118
DOI: 10.32677/ijch.2018.v05.i09.002